I’m sure they did think of the opportunity cost, as defined by the hurdle rate the returns on the Theranos deal had to clear in order to be justified. $140 million in comparison to the marginal revenue they probably projected from the deal is, even if at that point they were mostly sure it was fraudulent, pretty…